RRML - Real-time qPCR for assessment of minimal residual disease in acute myeloid and lymphoid leukemia
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2016): 55%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- October 2020 -
 
Romanian Review of Laboratory ... 17
High frequency of BRCA recurre... 16
Antibacterial and antitumor ac... 14
Troubleshootings in RNA extrac... 14
Metabolomic biomarkers of poly... 13
Carbapenemase Producing Entero... 10
Evaluation of oxidative stress... 10
The association of anthropomet... 10
Characterization of antibiotic... 9
Comparative Evaluation of RNAl... 9

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 19(4)/2011
XML
TXT

Real-time qPCR for assessment of minimal residual disease in acute myeloid and lymphoid leukemia

Dumitru Jardan, Rodica Talmaci, Cerasela Jardan, Daniel Coriu, Anca Colita, Andrei Colita, Constantin Arion


Abstract:

Evaluation of minimal residual disease is of major importance in the course of acute leukemia treatment. There are a number of technologies used in this regard, all of them exhibiting different limitations. Real time qPCR is one of the main technologies enabling gene expression analysis and is well suited for minimal residual disease monitoring of acute leukemia patients. cDNA of eight most common fusion genes was cloned - PML-RARα, TEL-AML1, AML-ETO, E2A-PBX1, SIL-TAL1, CBFβ-MYH11, MLL-AF4, BCR-ABL1. Serial dilution of cloned plasmids were prepared and used as standards for real-time qPCR. Sensitivity and overall performance of the method was evaluated as previously described. Overall testing demonstrated robustness of TaqMan technology for gene expression analysis. High reproducibility with low levels of both inter and intra run variation was obtained. Sensitivity exhibited by the assay was comparable to nested PCR which allowed early relapse detection for a number of patients.

Keywords: real-time qPCR,acute leukemia,minimal residual disease.

 
  PDF Download full text PDF
(370 KB)
     
 
How to cite
Jardan D, Talmaci R, Jardan C, Coriu D, Colita A, Colita A, et al. Real-time qPCR for assessment of minimal residual disease in acute myeloid and lymphoid leukemia. Rev Romana Med Lab. 2011;19(4):349-57